LA JOLLA, Calif.--Peter Schultz, a professor of chemistry at University of California, Berkeley, has been named head of the new Novartis Institute for Functional Genomics here. Novartis announced in April that it will invest a total of $250 million over 10 years in the institute, which will be located adjacent to the new Novartis Agricultural Discovery Institute and Scripps Research Institute.
Schultz said he will equip a group of highly creative chemists, biologists, and engineers with powerful new genomic and chemical technologies to establish the institute as a world-class leader in bio medical research. Schultz has 15 years experience in organic chemistry and biomedical research, has won a number of awards, and is a member of the National Academy of Sciences. He will assume the new post January 1.